SURG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SurgePays Inc (SURG) is not a good buy for a beginner investor with a long-term strategy at this time. The stock's technical indicators are bearish, the company has reported declining revenues and weak financial performance, and there are no strong positive catalysts or trading signals to suggest an immediate upside. Given the investor's preference for long-term investments, it would be prudent to wait for signs of financial recovery or stronger growth potential before considering an entry.
The technical indicators for SURG are bearish. The MACD is negative and expanding downward, the RSI is neutral at 43.701, and the moving averages are in a bearish sequence (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 0.694, with support at 0.514 and resistance at 0.873.
NULL identified. There are no significant insider or hedge fund trading trends, and no recent congress trading data. The stock has a 70% chance of modest short-term gains (2.26% in the next day, 3.2% in the next week, 8.99% in the next month), but this is not sufficient for a long-term investment thesis.
The company reported a revenue decline of 6.3% YoY for 2025, missing expectations by $4.94 million. The expiration of the Affordable Connectivity Program has negatively impacted revenues. Additionally, gross margin dropped significantly to -14.92%, and net income decreased by -47.54% YoY. Analysts have lowered the price target from $9.75 to $5, citing weaker Q4 revenue.
The company's financial performance has been weak. In 2025/Q3, revenue increased by 291.65% YoY to $18.68 million, but net income dropped by -47.54% YoY to -$7.49 million. EPS also declined by -47.95% YoY to -$0.38, and gross margin fell sharply by -91.23% YoY to -14.92%.
Analysts maintain a Buy rating but have significantly lowered the price target from $9.75 to $5. They expect a growth rebound in 2026, but this is speculative and does not align with the current financial and operational challenges.
